Natera Inc. Common Stock vs Solaredge Technologies Inc — how do they compare? Natera Inc. Common Stock trades at $394 (market cap $57.03B), while Solaredge Technologies Inc trades at $30.1 (market cap $2.00B). The key difference: Natera Inc. Common Stock is far larger — about 28.5× Solaredge Technologies Inc's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Solaredge Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Solaredge Technologies Inc for 34 Days on average.
| NTRA | SEDG | |
|---|---|---|
Market Cap | $57.03B | $2.00B |
Volume | 1,131,157 | 2,563,287 |
Sector | Health | Energy |
52-Week High | $425.64 | $78.51 |
52-Week Low | $179.42 | $28.47 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $56.18B | $1.86B |
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
SolarEdge Technologies (SEDG) trades at $30.52, down 3.05% on the day, as the stock faces bearish technical signals and ongoing financial challenges. The company reported a net loss of $405.45 million in 2025 despite revenue growth to $1.18 billion, with negative profit margins and declining cash flow trends. Recent news highlights multiple law firm investigations into investor claims, creating additional headwinds alongside sector-wide pressure from high borrowing costs affecting solar project financing.
The outlook remains challenging with bearish technical indicators and fundamental weaknesses, though analyst consensus suggests potential upside to $37.75. Key risks include ongoing financial losses, competitive pressures, and legal investigations, while opportunities exist in the company's AI data center initiatives and long-term revenue targets of $2.4 billion by 2029.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →